Background
Migraine is a chronic headache disorder and its recurrent attacks have a significant impact on patients’ daily life. A range of therapeutic options primarily from other indications exists, but low tolerability and insufficient response are reported to affect treatment success. Treatment options are often reevaluated, but no data on treatment algorithm and treatment failures exist. PANORAMA aimed at collecting data to characterize the health care landscape in Germany and to understand the current medical need for migraine patients.
Methods
119 headache and neurology centers participated in PANORAMA. PANORAMA was divided into three parts; the first part was an interview to generate an individual center profile, in the second part, the centers conducted a database research to characterize the migraine patients and the third part was an expert interview, to define the significance of migraine therapy at the center. 
Results
On average 13.8% of all patients in each center are migraine patients. 88.2% are collaborating with other centers mainly to validate therapeutic decisions.  82.5% of patients currently receive acute treatment of which 66.2% take triptans. 41.6% of patients receive prophylactics, the majority being beta-blockers (35.6%). 16.6% of the patients are already on their third prophylactic treatment and 90.7% of doctors see a high need for new preventive treatments such as monoclonal antibodies. 
Conclusion
The PANORAMA study gives a comprehensive overview of the health care landscape and elucidates the lack of treatment algorithms for migraine patients in Germany. Further PANORAMA reveals a high demand for new treatment options.

CHARACTERIZATION OF THE GERMAN HEALTH CARE LANDSCAPE OF MIGRAINE PATIENTS IN THE DATA COLLECTION PANORAMA